May 17, 2020

Why implementing WebRTC will benefit consumers

WebRTC
healthcare
telehealth
JT Ripton
Admin
2 min
WebRTC will enable consumers to receive medical care anywhere.
Last Monday, Healthcare Global took an in-depth look at WebRTC, and how it will revolutionize the healthcare industry.

In the second of our two-part se...

Last Monday, Healthcare Global took an in-depth look at WebRTC, and how it will revolutionize the healthcare industry.

In the second of our two-part series, we’ll examine how WebRTC will enable companies to provide a benefit that consumers have been asking about for decades: including the ability to receive medical care anywhere.

Companies that are among the first to implement this new, high quality video standard in telehealth will give themselves a distinct first move advantage in the space. With the telehealth market projected to grow from $240 million in 2014 to $1.9 billion in 2018, this will become an increasingly profitable advantage year over year, and it will simultaneously provide businesses with the ability to address the explosion in need for adult primary care services across the country.

RELATED TOPIC: Emerging telemedicine companies selected for Investor and Strategic Summit

The WebRTC Options

WebRTC builds security and encryption right into the standard, making it a technology available that offers the ability to implement video that fosters user adoption in a way that can be HIPAA compliant.

The core WebRTC technologies from Google and others are free and open source, and if hospital systems and doctor office’s prefer a pre-packaged and easier to implement video communications software development kit (SDK), they may want to pay a little for one with pre-built libraries and cloud services from a wide range of WebRTC infrastructure companies like those found on webrtcindex.com.

RELATED TOPIC: 4 Reasons Telemedicine Will Trend Upward in 2015

Additionally, WebRTC offers distinct advantages in a mobile environment where companies, such as Agora.io, are specifically supporting high-quality global access from mobile devices with relatively low needs in terms of processor power.

This is important if patients access the Internet primarily through their smartphones or are in remote areas and other countries with challenging network conditions.

RELATED TOPIC: 3 Things Telemedicine Needs to Succeed in 2015

The market for telehealth services is growing by the day, and implementing WebRTC will only speed up that growth in new services coming to the market.

Companies like Agora labs are providing frameworks for firms looking to take advantage of that growth through their SDK that will help speed up the development and deployment process among telehealth firms.

If your hospital system or doctor’s office is thinking of investing in telehealth today, make sure you are exploring WebRTC and related real-time communication technologies to drive the ongoing growth of your medical firm.

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article